This article relies largely or entirely on a
single source. (January 2024) |
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | OX-40 ligand |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6424H9920N1704O2014S42 |
Molar mass | 144594.46 g·mol−1 |
![]() ![]() |
Oxelumab is a human monoclonal antibody designed for the treatment of asthma. [1]
Oxelumab was developed by Genentech and co-developed by Roche.